Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 47 of 47 entries
View as:

A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02119819 Org: User:
Start: 04/30/14 End: 10/31/15 Due: 10/31/16

Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Phase: N/A Priority: Normal
NCT ID: NCT02500316 Org: User:
Start: 02/28/14 End: 11/30/23 Due: 11/30/24

Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03406377 Org: User:
Start: 04/02/18 End: 06/27/19 Due: 06/27/20

Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT00306904 Org: User:
Start: 01/31/06 End: 12/31/07 Due: 12/31/08

Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT03588884 Org: User:
Start: 06/08/18 End: 04/24/20 Due: 04/24/21

Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)

Phase: N/A Priority: Normal
NCT ID: NCT01219855 Org: User:
Start: 10/31/10 End: 11/30/11 Due: 11/30/12

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Phase: N/A Priority: Normal
NCT ID: NCT02968004 Org: User:
Start: 12/31/16 End: 05/31/24 Due: 05/31/25

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01735630 Org: User:
Start: 11/30/12 End: 05/31/15 Due: 05/31/16

A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

Phase: N/A Priority: Normal
NCT ID: NCT02418793 Org: User:
Start: 05/31/15 End: 09/30/18 Due: 09/30/19

A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT02188303 Org: User:
Start: 07/31/14 End: 12/31/14 Due: 12/31/15

Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT03874013 Org: User:
Start: 12/07/17 End: 03/06/20 Due: 03/06/21

A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations

Phase: N/A Priority: Normal
NCT ID: NCT03810664 Org: User:
Start: 01/18/19 End: 04/19/19 Due: 04/19/20

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI

Phase: N/A Priority: Normal
NCT ID: NCT03602261 Org: User:
Start: 07/09/18 End: 02/24/21 Due: 02/24/22

A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1

Phase: N/A Priority: Normal
NCT ID: NCT00239148 Org: User:
Start: 06/30/05 End: 12/31/06 Due: 12/31/07

Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin

Phase: N/A Priority: Normal
NCT ID: NCT00230854 Org: User:
Start: 08/31/05 End: 07/31/07 Due: 07/31/08

ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00934050 Org: User:
Start: 06/30/09 End: 06/30/11 Due: 06/30/12

4Kscore Using Serum Stored Uncentrifuged

Phase: N/A Priority: Normal
NCT ID: NCT04130776 Org: User:
Start: 10/04/17 End: 10/31/18 Due: 10/31/19

ELND005 in Patients With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00568776 Org: User:
Start: 12/31/07 End: 05/31/10 Due: 05/31/11

Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04551911 Org: User:
Start: 11/02/20 End: 10/08/21 Due: 10/08/22

A Prospective, Multicenter, Open-label, Safety and Preliminary Efficacy Study of the Surgical Implantation of OPKO's Glaucoma Drainage Device (AquashuntTM) in Patients With Refractory Chronic Forms of Open Angle Glaucoma (OAG)

Phase: N/A Priority: Normal
NCT ID: NCT00834223 Org: User:
Start: 01/31/09 End: 05/31/10 Due: 05/31/11

Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002

Phase: N/A Priority: Normal
NCT ID: NCT02282813 Org: User:
Start: 04/30/13 End: 05/31/15 Due: 05/31/16

Effects of TT301 on Cytokine Levels Post Endotoxin Challenge

Phase: N/A Priority: Normal
NCT ID: NCT01357421 Org: User:
Start: 05/31/11 End: 06/30/11 Due: 06/30/12